FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the prevention and treatment of bacterial infections and discloses products and a pharmaceutical composition, containing an antibiotic agent and a second agent in synergistically effective amounts, wherein the antibiotic agent is a peptide or non-peptide antibiotic, and the second agent is cysteamine.
EFFECT: group of inventions demonstrates improved antibacterial activity due to synergetic effect and can be used in medicine/veterinary science, as well as in agriculture.
19 cl, 2 tbl, 1 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION COMPRISING AN ANTIBIOTIC AND A DISPERSANT OR AN ANTI-ADHESIVE AGENT | 2011 |
|
RU2607660C2 |
| INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| USING ALGINATE OLIGOMERS IN BIOFILM CONTROL | 2008 |
|
RU2527894C2 |
| ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE THEREOF | 2014 |
|
RU2662764C2 |
| CEFTAROLINE-INCLUDING COMPOSITIONS AND METHODS OF TREATMENT | 2009 |
|
RU2524665C2 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
| LYSINE POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA | 2016 |
|
RU2724545C2 |
| IDENTIFICATION OF LYSINES AND THEIR DERIVATIVES WITH ANTIBACTERIAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA | 2018 |
|
RU2807688C2 |
| MICROPARTICLES CONTAINING SULFUR-CONTAINING COMPOUNDS | 2017 |
|
RU2780397C2 |
